Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes

By Kim J.J.   Nottingham L.K.   Wilson D.M.   Bagarazzi M.L.   Tsai A.   Morrison L.D.   Javadian A.   Chalian A.A.   Agadjanyan M.G.   Weiner D.B.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1828-1835

Elsevier

Access to resources Recommend Favorite

Site-directed immune responses in DNA vaccines encoding ligand-antigen fusions

By Lew A.M.A.M.   Brady B.J.L.   Boyle B.J.S.  

Vaccine, Vol. 18, Iss. 16, 2000-02 ,pp. : 1681-1685

Elsevier

Access to resources Recommend Favorite

The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation

By Kalus R.M.   Kantor J.A.   Gritz L.   Yafal A.G.   Mazzara G.P.   Schlom J.   Hodge J.W.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 893-903

Elsevier

Access to resources Recommend Favorite

Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines

By Heijtink R.A.   van Bergen P.   Paulij W.P.   de Man R.A.   Osterhaus A.D.M.E.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1531-1538

Elsevier

Access to resources Recommend Favorite

Modulation of the antigen presentation activity in foot and mouth disease virus (FMDV) vaccines by two adjuvants: avridine and a water soluble fraction of Mycobacterium sp.

By Wigdorovitz A.   Zamorano P.   Borca M.V.   Sadir A.M.  

Vaccine, Vol. 16, Iss. 17, 1998-10 ,pp. : 1627-1632

Elsevier

Access to resources Recommend Favorite